Small intestine neuroendocrine tumour

1 trials 1 recruiting MedDRA PT
1 Registered trials
1 Recruiting
1 Unique sponsors
1 Unique IMPs
0 Commercial trials
Drug classes (ATC)
V Various (ATC V) 1
Mechanism of action (INN-stem analysis)
Radiopharmaceutical 1 substance
Phase III: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase III

1 trial
  • Philipps-Universitaet Marburg Academic
    LUTETIUM (177LU) OXODOTREOTIDE
    2024-518236-36-00 1 country 2026 n=160 Orphan
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Philipps-Universitaet Marburg Academic 1 Phase III 1
New trials by year
2026
1
← All indication landscapes